Prevention of Potential Adverse Metabolic Effects of a Supplementation with Omega-3 Fatty Acids Using a Genetic Score Approach.

Abstract

INTRODUCTION:

The consumption of long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA) has been reported to have beneficial health effects, notably, by reducing plasma triglyceride levels. Nonetheless, a concomitant decrease in insulin sensitivity has also been observed, but is highly variable among subjects. Herein, we aimed to determine the importance of the genetic background in the interindividual variability of the insulin sensitivity response following an n-3 PUFA supplementation.

METHODS:

A total of 210 participants completed a 6-week n-3 PUFA supplementation with 5 g/day of fish oil (providing 1.9-2.2 g of eicosapentaenoic acid + 1.1 g of docosahexaenoic acid). Insulin resistance was estimated by the homeostatic model assessment (HOMA-IR), and participants were further classified as high-risk or low-risk depending on their HOMA-IR change following the n-3 PUFA supplementation, as compared to pre-supplementation values. Genome-wide genotyping data were obtained for 138 participants using HumanOmni-5-Quad BeadChips containing 4,301,331 single nucleotide polymorphisms. A genome-wide association analysis (GWAS) was carried out between high-risk and low-risk participants. The population study was split into training (60%) and testing (40%) datasets to assess the predictive accuracy of a genetic risk score (GRS) constructed by summing the number of risk alleles.

RESULTS:

Following the n-3 PUFA supplementation, 32 participants had increased HOMA-IR as compared to initial values and were classified as high risk (23.2%), whereas remaining subjects were classified as low risk (n = 106, 76.8%). A total of 8 loci had frequency differences between high-risk and low-risk participants at a suggestive GWAS association threshold (p value <1 × 10-5). After applying 10-fold cross validation, the GRS showed a significant association with the risk of increased HOMA-IR in the testing dataset (OR = 3.16 [95% CI, 1.85-7.14]), with a predictive accuracy of 0.85, and explained 40% of variation in HOMA-IR change.

CONCLUSIONS:

These results suggest that the genetic background has a relevant role in the interindividual variability observed in the insulin sensitivity response following an n-3 PUFA supplementation. Subjects being at risk of insulin sensitivity lowering following an n-3 PUFA supplementation may be identified using genetic-based precision nutrition approaches.

• Authors: Maximilien Franck, Juan de Toro-Martín, Frédéric Guénard, Iwona Rudkowska, Simone Lemieux, Benoît Lamarche, Patrick Couture, Marie-Claude Vohl
• Journal: Lifestyle genomics (Lifestyle Genom) Vol. 13 Issue 1 Pg. 32-42 ( 2020) ISSN: 2504-3188 [Electronic] Switzerland
• PMID: 31779001 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
• Copyright: © 2019 The Author(s) Published by S. Karger AG, Basel.

Chemical References

• Fatty Acids, Omega-3
• Fish Oils
• Docosahexaenoic Acids
• Eicosapentaenoic Acid

Topics

• Adult
• Alleles
• Body Mass Index
• Cross-Over Studies
• Dietary Supplements (adverse effects)
• Docosahexaenoic Acids (metabolism)
• Eicosapentaenoic Acid (metabolism)
• Fatty Acids, Omega-3 (metabolism)
• Female
• Fish Oils (therapeutic use)
• Genetic Variation
• Genome
• Genome-Wide Association Study
• Genotype
• Homeostasis
• Humans
• Insulin Resistance
• Male
• Polymorphism, Single Nucleotide
• Reproducibility of Results
• Risk
• Young Adult